Global Reconstructive Surgery Market, By Indication (Congenital Anomalies, Orthognathic Surgeries, Breast Reconstruction, Skin Cancer, Tissue Expansion, Hand Surgery, Lymphedema Treatment, Septoplasty, and Others), Prosthetic Implant (Tubes, Rings, Stents, Implants, and Others), End-User (Ambulatory Surgical Units, Hospitals, Clinics, and Others) – Industry Trends and Forecast to 2029.
Reconstructive Surgery Market Analysis and Size
The surgery performed to restore the shape or functionality of the body is known as reconstructive surgery. It primarily treats those body parts which are shaped abnormally or are dysfunctional. Such abnormalities can be caused by a variety of conditions, including congenital flaws, developmental abnormalities, trauma, infections, or other diseases.
Data Bridge Market Research analyses that the reconstructive surgery market which was USD 46 billion in 2021, would rocket up to USD 61.04 billion by 2029, and is expected to undergo a CAGR of 3.60% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Reconstructive Surgery Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Congenital Anomalies, Orthognathic Surgeries, Breast Reconstruction, Skin Cancer, Tissue Expansion, Hand Surgery, Lymphedema Treatment, Septoplasty, and Others), Prosthetic Implant (Tubes, Rings, Stents, Implants, and Others), End-User (Ambulatory Surgical Units, Hospitals, Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Medtronic (Ireland), Johnson & Johnson Private Limited (U.S.), General Electric (U.S.), Siemens (Germany), Baxter (U.S.), Fresenius Medical Care (Germany), Koninklijke Philips N.V. (Netherlands), Accurate Surgical & Scientific Instruments Corporation (U.S.), KLS Martin Group (Germany), Integra LifeSciences (U.S.), Tekno-Medical Optik-Chirurgie GmbH (Germany), Zimmer Biomet (U.S.), B. Braun Melsungen AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Reconstructive surgery is used to treat aesthetically and functionally compromised body structures caused by congenital defects, trauma, infection, developmental abnormalities, tumours, or disease. Reconstructive surgery is performed to improve the function and ability of the affected structure as well as to achieve a more typical appearance, and recovery time is approximately 6-8 weeks.
Global Reconstructive Surgery Market Dynamics
Drivers
- Increased demand of breast reconstruction
Breast reconstruction is growing rapidly due to an increase in breast cancer symptoms among the global female population. In 2015 and 2016, nearly 6 million reconstructive surgery procedures were performed, according to the American Society of Plastic Surgeons.
Furthermore, the market is predicted to expand quickly because of ageing population, rising rates of cancer and spinal illnesses, an increase in craniosynostosis operations, shifting lifestyles, patients' increased awareness of reconstructive surgery, and rising per capita spending. Additionally, economic development encourages the development of the health care system in developing nations like China and India. These factors support the expansion of the reconstructive surgery market.
- Advancement in reconstructive surgery
Restoration of tissues and organs in modern medicine has advanced significantly over time. For instance, using a piece of the patient's fibula bone and the nearby soft tissue and blood vessels, physicians can create a new jaw for a car accident victim by employing the technique known as autografting. The body is put through a lot of strain during autografting, which typically has negative health effects. Using stem cells grown from dental pulp, the soft tissue inside the tooth, and capillary-forming endothelial cells, a Technion-Israel Institute of Technology team developed blood vessels for enhanced tissue remodelling and repair. Therefore, by adopting these techniques, patients might acquire a lab-grown bone that completely matches the form of their face, surrounded by lab-grown soft tissues based on their cells created using 3D biomaterials. These all are some of the factors which propel the market growth.
Opportunities
- Microsurgery advancements
Microsurgery advancements have made lower extremity reconstruction possible even after significant soft tissue loss or tibial nerve disruption. The indications for amputation versus salvage, as well as the flap selection protocols for different areas of the lower extremity, are undergoing a paradigm shift. This will create a beneficial opportunity to the market.
Restraints/Challenges
- High risk in surgical procedures
Reconstructive surgery carries only a small number of risks, such as issues with anaesthesia, bleeding, blood clots, infection, healing issues, and fatigue (tiredness).
In addition, the market is anticipated to be hampered in the forecast period by the high cost of devices and implants and the preference for pharmaceuticals over treatment devices.
This reconstructive surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the reconstructive surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Reconstructive Surgery Market Scope
The reconstructive surgery market is segmented on the basis of indication, prosthetic implant and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Congenital Anomalies
- Orthognathic Surgeries
- Breast Reconstruction
- Skin Cancer
- Tissue Expansion
- Hand Surgery
- Lymphedema Treatment
- Septoplasty
- Others
Prosthetic Implant
- Tubes
- Rings
- Stents
- Implants
- Others
End-User
- Ambulatory Surgical Units
- Hospitals
- Clinics
- Others
Reconstructive Surgery Market Regional Analysis/Insights
The reconstructive surgery market is analysed and market size insights and trends are provided by country, indication, prosthetic implant and end-user as referenced above.
The countries covered in the reconstructive surgery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the reconstructive surgery market due to rising cancer prevalence and incidence of spine disorders, as well as high per capita health-care costs in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to rising craniosynostosis surgeries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The reconstructive surgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for reconstructive surgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the reconstructive surgery market. The data is available for historic period 2010-2020.
Competitive Landscape and Reconstructive Surgery Market Share Analysis
The reconstructive surgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to reconstructive surgery market.
Some of the major players operating in the reconstructive surgery market are:
- Medtronic (Ireland)
- Johnson & Johnson Private Limited (U.S.)
- General Electric (U.S.)
- Siemens (Germany)
- Baxter (U.S.)
- Fresenius Medical Care (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Accurate Surgical & Scientific Instruments Corporation (U.S.)
- KLS Martin Group (Germany)
- Integra LifeSciences (U.S.)
- Tekno-Medical Optik-Chirurgie GmbH (Germany)
- Zimmer Biomet (U.S.)
- B. Braun Melsungen AG (Germany)
SKU-